In January 2017 the United States Anti-Doping Agency (USADA) has reported an anti-doping rule violation against the Athlete after his A and B samples tested positive for the prohibited substance Peroxisome Proliferator Activated Receptor δ (PPARδ) agonists.
After notification the Athlete submitted that he did not accept the test results and he requested a hearing.
Hereafter the Athlete failed to respond to communications of the American Arbitration Association (AAA). He didn’t file a statement in his defence nor did he attend the hearing from the AAA Commercial Arbitration Tribunal.
Considering the evidence and without the Athlete’s response the Sole Arbitrator concludes that the Athlete committed an anti-doping rule violation without grounds for a reduced sanction.
Therefore the AAA Commercial Arbitration Tribunal decides on 29 June 2017:
A.) The Athlete has committed an anti-doping rule violation under Article 2.2 of the Code for Use of a Prohibited Substance not involving a Specified Substance;
B.) The start date of the Athlete's period of Ineligibility is the date of this Award, namely 29 June 2017, and the period of ineligibility expires on 29 June 2021;
C.) Athlete's competitive results from the date of his positive test, December 10, 2016, and throughout the period of his Ineligibility, are to be disqualified, and any medals, points and prizes earned during that period shall be forfeited;
D.) The parties shall bear their own attorneys' fees and costs associated with this Arbitration;
E.) The administrative fees and expenses of the American Arbitration Association, and the compensation and expenses of the Arbitrator, shall be borne by USADA and the United States Olympic Committee; and
F.) This Award shall be in full and final resolution of all claims and counterclaims submitted to this Arbitration. All claims not expressly granted herein are hereby denied.
